Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 26 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 12/1/2008 First Published: 8/5/2005


1.		Phase III Randomized Study of a Human Papillomavirus 16/18 L1 Virus-Like Particle/AS04 Vaccine Versus a Control for the Prevention of Grade 2 or 3 Cervical Intraepithelial Neoplasia, Adenocarcinoma in Situ of the Cervix, or Invasive Cervical Cancer in Younger Healthy Participants

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				18 to 25				NCI				NCI-04-C-N191 NCI-590299/009, GSK-590299/009, NCT00128661


2.		Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Completed				18 to 25				Pharmaceutical / Industry				104772 NCT00250276


3.		Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Closed				26 and older				Pharmaceutical / Industry				104820 NCT00294047


4.		A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Completed				18 to 35				Pharmaceutical / Industry				106001 NCT00306241


5.		Human Papillomavirus (HPV) Vaccine Consistency and Non-Inferiority Trial in Young Adult Women.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Natural history/Epidemiology, Prevention				Closed				10 to 25				Pharmaceutical / Industry				107476 (M18) 107477 (M24), 107479 (M36), 107481 (M48), NCT00337818


6.		Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				18 to 35				Pharmaceutical / Industry				104479 NCT00344032


7.		Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Completed				18 to 35				Pharmaceutical / Industry				105926 NCT00345878


8.		Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GSK Biologicals' (GSK Bio) HPV-16/18 Vaccine

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Natural history/Epidemiology, Prevention				Closed				10 to 14				Pharmaceutical / Industry				104896 (month 18 FU) 104902 (month 24 FU), 104904 (month 36 FU), 104918 (month 48 FU), NCT00316706


9.		Safety of Co-Administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Natural history/Epidemiology, Prevention				Completed				11 to 18				Pharmaceutical / Industry				107682 NCT00369824


10.		Immunogenicity of GSK Bio's HPV Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Completed				18 to 45				Pharmaceutical / Industry				108933 NCT00423046

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute